MedPath

OXLUMO 94,5 mg/0,5 ml SOLUCION INYECTABLE

OXLUMO 94,5 mg/0,5 ml SOLUCION INYECTABLE

Commercialized
Register Number

1201496001

Prescription Type

Uso Hospitalario

Authorization Date

Dec 30, 2020

Dosage Form

SOLUCIÓN INYECTABLE

Route: VÍA SUBCUTÁNEA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1201496001
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
Yes
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

LUMASIRAN SODIOActive
Quantity: 100 mg
Name: LUMASIRAN SODIO

ATC CLASSIFICATION (3)

A16A
A16AX
A16AX18

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.